Cochlear Ltd. (CHEOF)
Cochlear Market Cap: 11.02B for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 55.83M |
| Kazia Therapeutics Ltd. | 11.51M |
| Immutep Ltd. | 416.30M |
| Propanc Biopharma, Inc. | 7.171M |
| Mesoblast Ltd. | 2.308B |
Market Cap Related Metrics
| PS Ratio | 7.248 |
| PEG Ratio | 1.738 |
| Price to Free Cash Flow | 129.13 |
| Price | 168.56 |
| Earnings Yield | 2.28% |
| PEGY Ratio | 1.738 |
| Operating PE Ratio | 33.52 |
| Normalized PE Ratio | 43.65 |